70 assets in Myeloproliferative Neoplasm

Therapeutic assets addressing Myeloproliferative Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Melphalan Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2/3	BBB (72)
Fludarabine Myeloproliferative Neoplasm	Sawa Ito, MD	P4	BB (71)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Myeloproliferative Neoplasm	Fred Hutchinson Cancer Center	P2/3	BB (70)
Nivestim Myeloproliferative Neoplasm	City of Hope Medical Center	P3	BB (69)
Romidepsin Myeloproliferative Neoplasm	Sawa Ito, MD	P4	BB (69)
Busulfanum Myeloproliferative Neoplasm	Sawa Ito, MD	P4	BB (68)
Cyclosporin A Myeloproliferative Neoplasm	City of Hope Medical Center	P3	BB (68)
Etoposide Myeloproliferative Neoplasm	Memorial Sloan Kettering Cancer Center	P3	BB (68)
Decitabine Myeloproliferative Neoplasm	Jacqueline Garcia, MD	P2	BB (67)
Azacitidine Myeloproliferative Neoplasm	Prelude Therapeutics	P2	BB (66)
Cytarabine Myeloproliferative Neoplasm	Fred Hutchinson Cancer Center	P3	BB (66)
Methotrexate Myeloproliferative Neoplasm	The First Affiliated Hospital of Soochow University	P3	BB (66)
Sirolimus Myeloproliferative Neoplasm	Masonic Cancer Center, University of Minnesota	P3	BB (66)
Tacrolimus Myeloproliferative Neoplasm	Stanford University	P3	BB (66)
Cladribine Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P2	BB (65)
Cyclophosphamide Myeloproliferative Neoplasm	Sawa Ito, MD	P3	BB (65)
Peripheral Blood Stem Cells, Allogeneic, Cd34 Positive Myeloproliferative Neoplasm	Fred Hutchinson Cancer Center	P2	BB (64)
Thiotepa Myeloproliferative Neoplasm	Sawa Ito, MD	P2/3	BB (64)
Allopurinol Myeloproliferative Neoplasm	Masonic Cancer Center, University of Minnesota	P2	B (63)
Prednisone Myeloproliferative Neoplasm	The First Affiliated Hospital of Soochow University	P2	B (63)
Ruxolitinib Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2	B (63)
Venetoclax Myeloproliferative Neoplasm	Children's Hospital Medical Center, Cincinnati	P2	B (63)
Bendamustine Myeloproliferative Neoplasm	St. Petersburg State Pavlov Medical University	P2	B (62)
Daunomycin Myeloproliferative Neoplasm	Children's Oncology Group	P3	B (62)
Ivosidenib Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P2	B (62)
Sorafenib Myeloproliferative Neoplasm	St. Petersburg State Pavlov Medical University	P2	B (62)
Treg Cells Myeloproliferative Neoplasm	Stanford University	P2	B (62)
Cpx-351 Myeloproliferative Neoplasm	National Cancer Institute (NCI)	P2	B (60)
Mitoxantrone Myeloproliferative Neoplasm	University of Washington	P3	B (60)
Clofarabine Myeloproliferative Neoplasm	Memorial Sloan Kettering Cancer Center	P2	B (59)
Idarubicin Myeloproliferative Neoplasm	Fred Hutchinson Cancer Center	P2	B (58)
Pomalidomide Myeloproliferative Neoplasm	National Cancer Institute (NCI)	P2	B (58)
Asparaginase Myeloproliferative Neoplasm	Children's Oncology Group	P3	B (57)
Crisantaspase Myeloproliferative Neoplasm	Children's Oncology Group	P3	B (57)
Human Immunoglobulins Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2	B (57)
Thioguanine Anhydrous Myeloproliferative Neoplasm	Children's Oncology Group	P3	B (57)
Nadravaleucel Myeloproliferative Neoplasm	David Wald	P1/2	CCC (55)
Letermovir Myeloproliferative Neoplasm	City of Hope Medical Center	P2	CCC (54)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Myeloproliferative Neoplasm	City of Hope Medical Center	P2	CCC (54)
Abatacept Recombinant Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2	CCC (53)
Dexrazoxane Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P2	CCC (53)
Fedratinib Myeloproliferative Neoplasm	University of Washington	P2	CCC (53)
Gemtuzumab Ozogamicin Myeloproliferative Neoplasm	M.D. Anderson Cancer Center	P2	CCC (53)
Hpc, Cord Blood Myeloproliferative Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (53)
L-Ofloxacin Myeloproliferative Neoplasm	University of Manitoba	P2	CCC (53)
Mesna Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2	CCC (53)
Monalizumab Myeloproliferative Neoplasm	Istituto Clinico Humanitas	P2	CCC (53)
Olverembatinib Myeloproliferative Neoplasm	The First Affiliated Hospital of Soochow University	P2	CCC (53)
Pbsc Myeloproliferative Neoplasm	Fred Hutchinson Cancer Center	P2	CCC (53)
Ptcy Myeloproliferative Neoplasm	Center for International Blood and Marrow Transplant Research	P2	CCC (53)

Showing 1 to 50 of 70 assets

PreviousPage 1 of 2Next